Colistimethate Injection, Powder, For Solution
Product Images NDC 70594-023

3 FDA label images from Xellia Pharmaceuticals Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colistimethate (NDC 70594-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Colistimethate 01)

Chemical Structure (Colistimethate 01)
Chemical structure diagram of Colistimethate Sodium showing its peptide backbone with multiple L-Dbu, L-Thr, L-Leu residues and attached sulfate groups represented by O=S=O and sodium ions (Na).*
FDA Label Image

Figure 1 (Colistimethate 02)

Figure 1 (Colistimethate 02)
A line graph showing colistimethate base activity (mcg/mL) over time (hours) in urine and serum following intramuscular (IM) or intravenous (IV) administration in adults. The graph has two sets of lines: solid for IV and dashed for IM, depicting higher urine concentrations than serum, both decreasing over 12 hours.*
FDA Label Image

Principal Display Panel (150 mg Vial Carton)

Principal Display Panel (150 mg Vial Carton)
Packaging label for Colistimethate for Injection, USP, 150 mg/vial as colistin base activity. The label indicates it is for intramuscular and intravenous use, Rx only, and distributed by Xellia Pharmaceuticals USA LLC. Storage instructions and dosage guidelines are provided, along with a barcode and manufacturer details stating Made in Denmark.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.